Theriva BiologicsTOVX
13F holders, Q4 2025 (December 31)21holders +1
7new positions
6sold out
$0.21avg. 13F price*
At the end of Q4 2025, 21 institutions reported holding Theriva Biologics Inc. (TOVX) in their 13F filings, up 1 from Q3 2025. 7 opened new positions and 6 sold out. The largest holders were Vanguard Group Inc. ($54K), Geode Capital Management, LLC ($45K) and Morgan Stanley ($42K).
- Company
- Theriva Biologics Inc.
- CUSIP
- 87164U508
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $78K |
| Exits | 6 | $45K |
All 13F filers, Q3 2025 → Q4 2025: 1,004,945 shares bought and 146,492 shares sold, net +858,453 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Vanguard Group Inc. | 0.00% | Add +1461.0% | 255,727 | $54K |
| Geode Capital Management, LLC | 0.00% | Add +651.8% | 212,087 | $45K |
| Morgan Stanley | 0.00% | New | 200,000 | $42K |
| UBS Group AG | 0.00% | Add +735.4% | 191,410 | $40K |
| Ikarian Capital, LLC | 0.00% | Reduce -6.6% | 112,076 | $24K |
| Two Sigma Securities, LLC | 0.00% | New | 42,893 | $9K |
| Two Sigma Investments, LP | 0.00% | Reduce -31.5% | 42,337 | $9K |
| DRW Securities, LLC | 0.00% | New | 41,745 | $9K |
| XTX Topco Ltd | 0.00% | Add +19.9% | 39,445 | $8K |
| StoneX Group Inc. | 0.00% | New | 37,217 | $8K |
| Barclays PLC | 0.00% | New | 32,569 | $7K |
| Bank of America Corp. | 0.00% | Add +38343.2% | 31,139 | $7K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -22.3% | 27,646 | $6K |
| Schwarz Dygos Wheeler Investment Advisors LLC | 0.00% | New | 15,000 | $3K |
| BlackRock, Inc. | 0.00% | Reduce -0.0% | 7,504 | $2K |
| Citigroup Inc. | 0.00% | Add +618800.0% | 6,189 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +0.9% | 448 | $93 |
| SBI Securities Co., Ltd. | 0.00% | No change | 59 | $12 |
| IFP Advisors, Inc | 0.00% | No change | 11 | $2 |
| NFSG Corp | 0.00% | New | 5 | $1 |
| Danske Bank A/S | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is TOVX's weight in each manager's 13F, not the share of Theriva Biologics Inc. the manager owns.